Cofacteurs de l’anaphylaxie : analyse des données du Réseau d’Allergo-Vigilance (2016–2020)
Tài liệu tham khảo
Niggemann, 2014, Factors augmenting allergic reactions, Allergy, 69, 1582, 10.1111/all.12532
Beaudouin, 2017, Rôle des cofacteurs dans l’anaphylaxie alimentaire, Rev Fr Allergol, 57, 551, 10.1016/j.reval.2017.09.002
Wölbing, 2013, About the role and underlying mechanisms of cofactors in anaphylaxis, Allergy, 68, 1085, 10.1111/all.12193
Turner, 2017, Fatal anaphylaxis: mortality rate and risk factors, J allergy Clin Immunol Pract, 5, 1169, 10.1016/j.jaip.2017.06.031
Reitter, 2014, Fatal anaphylaxis with neuromascular blocking agents: a risk factor and management analysis, Allergy, 69, 954, 10.1111/all.12426
Clark, 2014, Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatement in IS emergency departement and hospitals, J Allergy Clin Immunol, 134, 1125, 10.1016/j.jaci.2014.05.018
Worm, 2018, Factors increasing the risk for severe reaction in anaphylaxis: an analysis of data from European Anaphylaxis Registry, Allergy, 73, 1322, 10.1111/all.13380
Moneret-Vautrin, 2009, Drugs as risk factors of food. Anaphylaxis in adults: a case-control study, Bull Acad Natl Med, 193, 351
Regateiro, 2020, Drug-induced anaphylaxis: an update on epidemiology and risk factors, Int Arch Allergy Immunol, 181, 481, 10.1159/000507445
Dhopeshwarkar, 2019, Drug-induced anaphylaxis documented in electronic health records, J Allergy Clin Immunol Pract, 7, 103, 10.1016/j.jaip.2018.06.010
Pouessel, 2017, Mortalité par anaphylaxie en France Métropolitaine : analyse des données des données nationales de 1979 à 2011, Rev Fr Allergol, 57, 525, 10.1016/j.reval.2017.06.005
Rueff, 2009, Predictors of severe systemic anaphylactic reactions with hymenoptera venom allergy: importance of baseline serum tryptase–a study of the European Academy of Allergy and Clinical Immunology Interest Group on Insect Venom Hypersensitivity, J Allergy Clin Imunol, 124, 1047, 10.1016/j.jaci.2009.08.027
Turner, 2019, Time to revisit the definition and clinical criteria for anaphylaxis?, World Allergy Organ J, 12, 100066, 10.1016/j.waojou.2019.100066
Worm, 2017, Food-induced anaphylaxis and cofactors – data from the anaphylaxis registry, Allergol Select, 1, 21, 10.5414/ALX01401E
Munoz-Cano, 2017, Mecanism, cofactors and augmenting factors involved anaphylaxis, Front Immunol, 8, 1193, 10.3389/fimmu.2017.01193
Christensen, 2019, Exercise-induced anaphylaxis: causes, consequences and management recommendations, Expert Rev Clin Immunol, 15, 265, 10.1080/1744666X.2019.1562904
Fukata, 2009, Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders, Semin Immunol, 21, 242, 10.1016/j.smim.2009.06.005
Supajatura, 2002, Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, J Clin Invest, 109, 1351, 10.1172/JCI0214704
Wu, 2007, Bacterial pepti-doglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2, Immunol Cell Biol, 85, 538, 10.1038/sj.icb.7100079
Shin, 2021, Food allergies and food-induced anaphylaxis: role of cofactors, Clin Exp Pediatr, 64, 393, 10.3345/cep.2020.01088
Aihara, 2002, Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation, Br J Dermatol, 146, 466, 10.1046/j.1365-2133.2002.04601.x
Coop, 2017, Are ACE inhibitors and beta-blockers dangerous in patients at risk for anaphylaxis?, J Allergy Clin Immunol Prat, 5, 2107
Francuzik, 2015, Impact of sex on anaphylaxis severity — data from the Anaphylaxis Registry, J Allergy Clin Immunol, 136, 1425, 10.1016/j.jaci.2015.06.052
Webb, 2006, Anaphylaxis: a review of 601 cases, J Allergy Clin Immunol, 97, 39
Liew, 2009, Anaphylaxis fatalities and admissions in Australia, J Allergy Clin Immunol, 123, 434, 10.1016/j.jaci.2008.10.049
Liberman, 2014, Catamenial anaphylaxis, J Allergy Clin Immunol Pract, 2, 358, 10.1016/j.jaip.2014.03.005
Hox, 2015, Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production, J Allergy Clin Immunol, 135, 10.1016/j.jaci.2014.11.003
Muraro, 2014, Anaphyalxis: guidelines from European Academy of Allergy and Clinical Immunology, Allergy, 69, 1026, 10.1111/all.12437
Simons, 2015, 2015 update of evidence base: World Allergy Organisation ana- phylaxis guidelines, World Allergy Organ J, 8, 32, 10.1186/s40413-015-0080-1
Bock, 2007, Further fatalities caused by anaphylactic reactions to food, 2001-2006, J Allergy Clin Immunol, 119, 1016, 10.1016/j.jaci.2006.12.622
XU, 2014, Anaphyaxis-related death in Ontario: a retrospective review of cases from 1986 to 2011, Allergy Asthma Clin Immunol, 10, 38, 10.1186/1710-1492-10-38
Triggiani, 2014, Anaphylaxis and cardiovascular diseases: a dangerous liaison, Curr Opin Allergy Clin Immunol, 14, 309, 10.1097/ACI.0000000000000071
Kounis, 2017, Kounis syndrome: a review article on epidemiology, diagnostic findings, management and complications of allergic acute coronarysyndrome: mastocytosis and post-mortem diagnosis, Intern J Cardiol, 242, 38, 10.1016/j.ijcard.2017.02.144
Kounis, 2016, Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management, Clin Chem Lab Med, 54, 1545, 10.1515/cclm-2016-0010
Nazir, 2017, Takotsubo cardiopathyassociated with epinephrine use: a systemic review and meta-analysis, Int J Cardio, 229, 67, 10.1016/j.ijcard.2016.11.266
O’Connell, 2020, Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia, Curr Opin Allergy Immunol, 20, 431, 10.1097/ACI.0000000000000678
Alvarez-Twose, 2019, Mastocytosis presenting as insect anaphylaxis: gender differences and natural history, Curr Opin Allergy Clin Immunol, 19, 468, 10.1097/ACI.0000000000000567
Alvares-Twose, 2012, Validation of REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms, Arch Allergy Immunol, 157, 275, 10.1159/000329856
Porebski, 2018, Protein-Coupled Receptor-X2 (MRGPRX2) in drug hypersensitivity reactions, Frontiers Immunol, 9, 3027, 10.3389/fimmu.2018.03027
Ebo, 2021, Mast cell activation during suspected perioperative hypersensitivity: a need for paired samples analysis, J Allergy Clin Immunol Pract, 9, 3051, 10.1016/j.jaip.2021.03.050
Tacquard, 2017, Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiologic survey, Acta Anaesthesiol Scand, 61, 290, 10.1111/aas.12855
Mertes, 2011, Anaphylaxis during anesthesia in France: an 8-year national survey, J Allergy Clin Immunol, 128, 366, 10.1016/j.jaci.2011.03.003
Harper, 2018, Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6), N Br J Anaesth, 121, 159, 10.1016/j.bja.2018.04.014
Gurrieri, 2011, Allergic reactions during anesthesia at a large United States referral center, Anesth Analg, 113, 1202, 10.1213/ANE.0b013e31822d45ac
Trautmann, 2016, Général anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia, Clin Exp Allergy, 46, 125, 10.1111/cea.12632
Bridgman, 2013, Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases, Anaesth Intensive Care, 41, 116, 10.1177/0310057X1304100120
Mertes PM, Demoly P, Stenger P, for the WAO Allergic Disease Resource Center, Perioperative Allergic Reactions,World Allergy Organization article 2019 updated.
Oropeza, 2017, Patterns of anaphylaxis after diagnostic workup: a follow-up study of 226 patients with suspected anaphylaxis, Allergy, 72, 1944, 10.1111/all.13207
Kucharewicz, 2007, Basal serum tryptase level correlates with severity of hymenoptera sting and age, J. Investig Allergol Clin Immunol, 17, 65
Haeberli, 2003, Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy, Clin Exp Allergy, 33, 1216, 10.1046/j.1365-2222.2003.01755.x
Greenberger, 2007, Fatal anaphylaxis: postmortem findings and associated comorbid diseases, Allergy Asthma Immunol, 98, 252, 10.1016/S1081-1206(10)60714-4
Wood, 2014, Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in United States, J Allergy Clin Immunol, 133, 461, 10.1016/j.jaci.2013.08.016
Asaumi, 2018, How to manage food dependent exercise induced anaphylaxis (FDEIA), Curr Opin Allergy Clin Immunol, 18, 243, 10.1097/ACI.0000000000000442
